Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Zimmer Biomet participates in a conference call with Truist » 12:45
08/03/22
08/03
12:45
08/03/22
12:45
ZBH

Zimmer Biomet

$115.09 /

+1.08 (+0.95%)

Medical Supplies &…

Medical Supplies & Devices Analysts Newitter and Brodovsky hold a conference call with Chief Communications & Administrative Officer Mattox and Treasurer Bagchi on August 3 at 1 pm hosted by Truist. Webcast Link

ShowHide Related Items >><<
ZBH Zimmer Biomet
$115.09 /

+1.08 (+0.95%)

ZBH Zimmer Biomet
$115.09 /

+1.08 (+0.95%)

08/03/22 Truist
Zimmer Biomet price target raised to $125 from $115 at Truist
08/03/22 Citi
Zimmer Biomet price target raised to $119 from $114 at Citi
08/02/22 Piper Sandler
Zimmer Biomet price target lowered to $120 from $130 at Piper Sandler
07/18/22 Stifel
Zimmer Biomet price target lowered to $120 from $140 at Stifel
ZBH Zimmer Biomet
$115.09 /

+1.08 (+0.95%)

ZBH Zimmer Biomet
$115.09 /

+1.08 (+0.95%)

ZBH Zimmer Biomet
$115.09 /

+1.08 (+0.95%)

Recommendations
Zimmer Biomet price target raised to $125 from $115 at Truist » 09:07
08/03/22
08/03
09:07
08/03/22
09:07
ZBH

Zimmer Biomet

$114.03 /

+4.32 (+3.94%)

Truist analyst Richard…

Truist analyst Richard Newitter raised the firm's price target on Zimmer Biomet to $125 from $115 and keeps a Hold rating on the shares. The analyst is more positive on the stock following its Q2 revenue growth acceleration, though his assumed 17.5-times forward earnings multiple also "appropriately" reflects the company's mid-single-digit topline and high-single-digits earnings growth prospects, Newitter tells investors in a research note.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

08/03/22 Citi
Zimmer Biomet price target raised to $119 from $114 at Citi
08/02/22 Piper Sandler
Zimmer Biomet price target lowered to $120 from $130 at Piper Sandler
07/18/22 Stifel
Zimmer Biomet price target lowered to $120 from $140 at Stifel
05/27/22 Needham
Needham cuts Zimmer Biomet to Hold, expects growth to slow
ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

Hot Stocks
NeuroOne Medical announces $3.5M accelerated payment from Zimmer Biomet » 09:04
08/03/22
08/03
09:04
08/03/22
09:04
NMTC

NeuroOne Medical

$1.20 /

+ (+0.00%)

, ZBH

Zimmer Biomet

$114.03 /

+4.32 (+3.94%)

NeuroOne Medical (NMTC)…

NeuroOne Medical (NMTC) announced that the company entered into an amendment to its Exclusive Development and Distribution Agreement with Zimmer Biomet (ZBH) that will provide the company with a $3.5M accelerated payment within 10 business days which relates to certain milestone payments. In addition, Zimmer Biomet will receive a Warrant to purchase 350,000 shares of the company's common stock, with an exercise price of $3.00 per share.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

NMTC NeuroOne Medical
$1.20 /

+ (+0.00%)

NMTC NeuroOne Medical
$1.20 /

+ (+0.00%)

03/29/22 Alliance Global Partners
NeuroOne price target lowered to $3.25 from $5.75 at Alliance Global Partners
03/28/22 Craig-Hallum
Craig-Hallum downgrades NeuroOne Medical to Hold, cuts price target to $2
03/28/22 Craig-Hallum
NeuroOne Medical Technologies downgraded to Hold from Buy at Craig-Hallum
12/03/21 Alliance Global Partners
NeuroOne Medical Technologies initiated with a Buy at Alliance Global Partners
ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

08/03/22 Citi
Zimmer Biomet price target raised to $119 from $114 at Citi
08/02/22 Piper Sandler
Zimmer Biomet price target lowered to $120 from $130 at Piper Sandler
07/18/22 Stifel
Zimmer Biomet price target lowered to $120 from $140 at Stifel
05/27/22 Needham
Needham cuts Zimmer Biomet to Hold, expects growth to slow
ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

  • 13
    Oct
ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

NMTC NeuroOne Medical
$1.20 /

+ (+0.00%)

ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

Recommendations
Zimmer Biomet price target raised to $119 from $114 at Citi » 06:27
08/03/22
08/03
06:27
08/03/22
06:27
ZBH

Zimmer Biomet

/

+

Citi analyst Joanne…

Citi analyst Joanne Wuensch raised the firm's price target on Zimmer Biomet to $119 from $114 and keeps a Neutral rating on the shares following the "good quarter."

ShowHide Related Items >><<
ZBH Zimmer Biomet
/

+

ZBH Zimmer Biomet
/

+

08/02/22 Piper Sandler
Zimmer Biomet price target lowered to $120 from $130 at Piper Sandler
07/18/22 Stifel
Zimmer Biomet price target lowered to $120 from $140 at Stifel
05/27/22 Needham
Needham cuts Zimmer Biomet to Hold, expects growth to slow
05/27/22 Needham
Zimmer Biomet downgraded to Hold from Buy at Needham
ZBH Zimmer Biomet
/

+

ZBH Zimmer Biomet
/

+

ZBH Zimmer Biomet
/

+

Conference/Events
Zimmer Biomet participates in a conference call with Truist » 04:55
08/03/22
08/03
04:55
08/03/22
04:55
ZBH

Zimmer Biomet

$114.03 /

+4.32 (+3.94%)

Medical Supplies &…

Medical Supplies & Devices Analysts Newitter and Brodovsky hold a conference call with Chief Communications & Administrative Officer Mattox and Treasurer Bagchi on August 3 at 1 pm hosted by Truist. Webcast Link

ShowHide Related Items >><<
ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

08/02/22 Piper Sandler
Zimmer Biomet price target lowered to $120 from $130 at Piper Sandler
07/18/22 Stifel
Zimmer Biomet price target lowered to $120 from $140 at Stifel
05/27/22 Needham
Needham cuts Zimmer Biomet to Hold, expects growth to slow
05/27/22 Needham
Zimmer Biomet downgraded to Hold from Buy at Needham
ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

ZBH Zimmer Biomet
$114.03 /

+4.32 (+3.94%)

Recommendations
Zimmer Biomet price target lowered to $120 from $130 at Piper Sandler » 12:20
08/02/22
08/02
12:20
08/02/22
12:20
ZBH

Zimmer Biomet

$115.65 /

+5.94 (+5.41%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien lowered the firm's price target on Zimmer Biomet to $120 from $130 and keeps a Neutral rating on the shares. Following Q2 results, the analyst believes the backlog of cases is starting to filter through the system, especially in OUS markets. O'Brien said that the Q2 report was an overall "nice" update" for Zimmer and it sounds like there will be a spate of new products dropping in the coming months, but he continues to see more attractive growth names across large cap med tech, which he continues to favor.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$115.65 /

+5.94 (+5.41%)

ZBH Zimmer Biomet
$115.65 /

+5.94 (+5.41%)

07/18/22 Stifel
Zimmer Biomet price target lowered to $120 from $140 at Stifel
05/27/22 Needham
Needham cuts Zimmer Biomet to Hold, expects growth to slow
05/27/22 Needham
Zimmer Biomet downgraded to Hold from Buy at Needham
05/17/22 Citi
Zimmer Biomet price target lowered to $125 from $135 at Citi
ZBH Zimmer Biomet
$115.65 /

+5.94 (+5.41%)

ZBH Zimmer Biomet
$115.65 /

+5.94 (+5.41%)

ZBH Zimmer Biomet
$115.65 /

+5.94 (+5.41%)

Options
Early notable gainers among liquid option names on August 2nd » 09:55
08/02/22
08/02
09:55
08/02/22
09:55
IT

Gartner

$289.50 /

+20.795 (+7.74%)

, XYL

Xylem

$97.35 /

+6.08 (+6.66%)

, MPWR

Monolithic Power

$491.00 /

+29.71 (+6.44%)

, AFL

Aflac

$58.70 /

+1.95 (+3.44%)

, ZBH

Zimmer Biomet

$115.51 /

+5.8 (+5.29%)

Notable gainers among…

Notable gainers among liquid option names this morning include Gartner (IT) $286.76 +17.66, Xylem (XYL) $97.02 +5.82, Monolithic Power (MPWR) $488.45 +26.15, AFLAC (AFL) $59.48 +2.77, and Zimmer Biomet (ZBH) $114.98 +5.22.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$115.51 /

+5.8 (+5.29%)

XYL Xylem
$97.35 /

+6.08 (+6.66%)

MPWR Monolithic Power
$491.00 /

+29.71 (+6.44%)

IT Gartner
$289.50 /

+20.795 (+7.74%)

AFL Aflac
$58.70 /

+1.95 (+3.44%)

IT Gartner
$289.50 /

+20.795 (+7.74%)

07/12/22 Wells Fargo
Gartner initiated with an Overweight at Wells Fargo
07/01/22 Barclays
Gartner price target lowered to $265 from $325 at Barclays
06/21/22 BMO Capital
Gartner price target lowered to $265 from $315 at BMO Capital
04/14/22 BofA
BofA upgrades Gartner to Buy, says stock not valuing 'robust' free cash flow
XYL Xylem
$97.35 /

+6.08 (+6.66%)

07/20/22 Stifel
Xylem upgraded to Buy from Hold at Stifel
07/18/22 Northcoast
Xylem initiated with a Neutral at Northcoast (Friday)
07/18/22 Mizuho
Xylem price target lowered to $80 from $85 at Mizuho
06/01/22 Cowen
Xylem upgraded to Market Perform from Underperform at Cowen
MPWR Monolithic Power
$491.00 /

+29.71 (+6.44%)

08/02/22 Cowen
Monolithic Power price target raised to $600 from $550 at Cowen
08/02/22 Raymond James
Monolithic Power price target lowered to $570 from $600 at Raymond James
08/02/22 Needham
Monolithic Power price target raised to $550 from $500 at Needham
08/02/22 Deutsche Bank
Monolithic Power price target raised to $530 from $457 at Deutsche Bank
AFL Aflac
$58.70 /

+1.95 (+3.44%)

07/11/22 JPMorgan
Aflac price target raised to $62 from $61 at JPMorgan
07/08/22 Piper Sandler
Aflac price target lowered to $66 from $68 at Piper Sandler
07/06/22 Evercore ISI
Aflac price target lowered to $59 from $60 at Evercore ISI
05/23/22 Citi
Citi starts 14 insurers, sees opportunity in life and caution on P&C
ZBH Zimmer Biomet
$115.51 /

+5.8 (+5.29%)

07/18/22 Stifel
Zimmer Biomet price target lowered to $120 from $140 at Stifel
05/27/22 Needham
Needham cuts Zimmer Biomet to Hold, expects growth to slow
05/27/22 Needham
Zimmer Biomet downgraded to Hold from Buy at Needham
05/17/22 Citi
Zimmer Biomet price target lowered to $125 from $135 at Citi
ZBH Zimmer Biomet
$115.51 /

+5.8 (+5.29%)

XYL Xylem
$97.35 /

+6.08 (+6.66%)

MPWR Monolithic Power
$491.00 /

+29.71 (+6.44%)

IT Gartner
$289.50 /

+20.795 (+7.74%)

AFL Aflac
$58.70 /

+1.95 (+3.44%)

ZBH Zimmer Biomet
$115.51 /

+5.8 (+5.29%)

XYL Xylem
$97.35 /

+6.08 (+6.66%)

MPWR Monolithic Power
$491.00 /

+29.71 (+6.44%)

IT Gartner
$289.50 /

+20.795 (+7.74%)

AFL Aflac
$58.70 /

+1.95 (+3.44%)

ZBH Zimmer Biomet
$115.51 /

+5.8 (+5.29%)

XYL Xylem
$97.35 /

+6.08 (+6.66%)

MPWR Monolithic Power
$491.00 /

+29.71 (+6.44%)

Earnings
Zimmer Biomet raises FY22 adjusted EPS view to $6.70-$6.90 from $6.65-$6.85 » 06:59
08/02/22
08/02
06:59
08/02/22
06:59
ZBH

Zimmer Biomet

$109.72 /

-0.66 (-0.60%)

Consensus $6.72. Raises…

Consensus $6.72. Raises FY22 revenue view to down 1% to up 1% from down 1.5% to up .5%, consensus $6.83B.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$109.72 /

-0.66 (-0.60%)

ZBH Zimmer Biomet
$109.72 /

-0.66 (-0.60%)

07/18/22 Stifel
Zimmer Biomet price target lowered to $120 from $140 at Stifel
05/27/22 Needham
Needham cuts Zimmer Biomet to Hold, expects growth to slow
05/27/22 Needham
Zimmer Biomet downgraded to Hold from Buy at Needham
05/17/22 Citi
Zimmer Biomet price target lowered to $125 from $135 at Citi
ZBH Zimmer Biomet
$109.72 /

-0.66 (-0.60%)

ZBH Zimmer Biomet
$109.72 /

-0.66 (-0.60%)

ZBH Zimmer Biomet
$109.72 /

-0.66 (-0.60%)

Earnings
Zimmer Biomet reports Q2 adjusted EPS $1.82, consensus $1.65 » 06:57
08/02/22
08/02
06:57
08/02/22
06:57
ZBH

Zimmer Biomet

$109.72 /

-0.66 (-0.60%)

Reports Q2 revenue…

Reports Q2 revenue $1.78B, consensus $1.72B. "Our performance in Q2 was well above our own internal expectations due to stronger than anticipated COVID recovery in the quarter and the continued execution from the ZB team across our regions and segments. Despite expected increased pressure from foreign exchange rates and inflation, we are once again updating our guidance," said Bryan Hanson, chairman, president and CEO of Zimmer Biomet. "We believe our focus on innovation and the transformation of our business continues to position us well for long-term growth and continued delivery for our shareholders."

ShowHide Related Items >><<
ZBH Zimmer Biomet
$109.72 /

-0.66 (-0.60%)

ZBH Zimmer Biomet
$109.72 /

-0.66 (-0.60%)

07/18/22 Stifel
Zimmer Biomet price target lowered to $120 from $140 at Stifel
05/27/22 Needham
Needham cuts Zimmer Biomet to Hold, expects growth to slow
05/27/22 Needham
Zimmer Biomet downgraded to Hold from Buy at Needham
05/17/22 Citi
Zimmer Biomet price target lowered to $125 from $135 at Citi
ZBH Zimmer Biomet
$109.72 /

-0.66 (-0.60%)

ZBH Zimmer Biomet
$109.72 /

-0.66 (-0.60%)

ZBH Zimmer Biomet
$109.72 /

-0.66 (-0.60%)

Conference/Events
Zimmer Biomet participates in a conference call with Truist » 13:15
07/27/22
07/27
13:15
07/27/22
13:15
ZBH

Zimmer Biomet

$109.31 /

+1.35 (+1.25%)

Medical Supplies &…

Medical Supplies & Devices Analysts Newitter and Brodovsky hold a conference call with Chief Communications & Administrative Officer Mattox and Treasurer Bagchi on August 3 at 1 pm hosted by Truist. Webcast Link

ShowHide Related Items >><<
ZBH Zimmer Biomet
$109.31 /

+1.35 (+1.25%)

ZBH Zimmer Biomet
$109.31 /

+1.35 (+1.25%)

07/18/22 Stifel
Zimmer Biomet price target lowered to $120 from $140 at Stifel
05/27/22 Needham
Needham cuts Zimmer Biomet to Hold, expects growth to slow
05/27/22 Needham
Zimmer Biomet downgraded to Hold from Buy at Needham
05/17/22 Citi
Zimmer Biomet price target lowered to $125 from $135 at Citi
ZBH Zimmer Biomet
$109.31 /

+1.35 (+1.25%)

ZBH Zimmer Biomet
$109.31 /

+1.35 (+1.25%)

ZBH Zimmer Biomet
$109.31 /

+1.35 (+1.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.